[Corrigendum] Effect of type 2 diabetes mellitus caveolin‑3 K15N mutation on glycometabolism

作者: Yiyuan Huang , Yufeng Deng , Lina Shang , Lihui Yang , Juanjuan Huang

DOI: 10.3892/ETM.2019.8307

关键词:

摘要: Caveolin-3 (CAV3) is a muscle-specific protein present within the muscle cell membrane that affects signaling pathways, including insulin pathway. A previous assessment of patients with newly developed type 2 diabetes (T2DM) demonstrated CAV3 gene mutations may lead to changes in secondary structure. severe P104L mutation has previously been indicated influence phosphorylation skeletal cells and result impaired glucose metabolism. In study, effect K15N transfection C2C12 was assessed. Transfection reduced expression total AKT2 proteins cells, translocation transporter 4 membrane, which resulted decreased uptake glycogen synthesis myocytes. conclusion, these results indicate cause insulin-stimulated metabolism myocytes, contribute development T2DM.

参考文章(60)
H. H. Patel, F. Murray, P. A. Insel, G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handbook of experimental pharmacology. ,vol. 186, pp. 167- 184 ,(2008) , 10.1007/978-3-540-72843-6_7
Yunfeng Gao, Mengna Zhang, Tianchen Wu, Mengying Xu, Haonan Cai, Zesheng Zhang, Effects of D-Pinitol on Insulin Resistance through the PI3K/Akt Signaling Pathway in Type 2 Diabetes Mellitus Rats. Journal of Agricultural and Food Chemistry. ,vol. 63, pp. 6019- 6026 ,(2015) , 10.1021/ACS.JAFC.5B01238
Min Yang, Yan Ren, Zhimin Lin, Chenchen Tang, Yanjun Jia, Yerui Lai, Tingting Zhou, Shaobo Wu, Hua Liu, Gangyi Yang, Ling Li, Krüppel-like factor 14 increases insulin sensitivity through activation of PI3K/Akt signal pathway Cellular Signalling. ,vol. 27, pp. 2201- 2208 ,(2015) , 10.1016/J.CELLSIG.2015.07.019
Kenneth S. Song, Philipp E. Scherer, ZhaoLan Tang, Takashi Okamoto, Shengwen Li, Mark Chafel, Caryn Chu, D. Stave Kohtz, Michael P. Lisanti, Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells Journal of Biological Chemistry. ,vol. 271, pp. 15160- 15165 ,(1996) , 10.1074/JBC.271.25.15160
Abdessattar Hadj Sassi, Julien Monteil, Patrick Sauvant, Claude Atgié, Overexpression of caveolin-3-enhanced protein synthesis rather than proteolysis inhibition in C2C12 myoblasts: relationship with myostatin activity. Journal of Physiology and Biochemistry. ,vol. 68, pp. 683- 690 ,(2012) , 10.1007/S13105-012-0192-9
Jacques Couet, Massimo Sargiacomo, Michael P. Lisanti, Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins: CAVEOLIN BINDING NEGATIVELY REGULATES TYROSINE AND SERINE/THREONINE KINASE ACTIVITIES * Journal of Biological Chemistry. ,vol. 272, pp. 30429- 30438 ,(1997) , 10.1074/JBC.272.48.30429
Carlo Minetti, Federica Sotgia, Claudio Bruno, Paolo Scartezzini, Paolo Broda, Massimo Bado, Emiliana Masetti, Michela Mazzocco, Aliana Egeo, Maria Alice Donati, Daniela Volonté, Ferruccio Galbiati, Giuseppe Cordone, Franca Dagna Bricarelli, Michael P. Lisanti, Federico Zara, Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nature Genetics. ,vol. 18, pp. 365- 368 ,(1998) , 10.1038/NG0498-365
Brendan D. Manning, Lewis C. Cantley, AKT/PKB signaling: navigating downstream. Cell. ,vol. 129, pp. 1261- 1274 ,(2007) , 10.1016/J.CELL.2007.06.009
Yousuke T. Horikawa, Mathivadhani Panneerselvam, Yoshitaka Kawaraguchi, Yasuo M. Tsutsumi, Sameh S. Ali, Ravi C. Balijepalli, Fiona Murray, Brian P. Head, Ingrid R. Niesman, Timo Rieg, Volker Vallon, Paul A. Insel, Hemal H. Patel, David M. Roth, Cardiac-Specific Overexpression of Caveolin-3 Attenuates Cardiac Hypertrophy and Increases Natriuretic Peptide Expression and Signaling Journal of the American College of Cardiology. ,vol. 57, pp. 2273- 2283 ,(2011) , 10.1016/J.JACC.2010.12.032
David A. Guertin, Deanna M. Stevens, Carson C. Thoreen, Aurora A. Burds, Nada Y. Kalaany, Jason Moffat, Michael Brown, Kevin J. Fitzgerald, David M. Sabatini, Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKCα, but Not S6K1 Developmental Cell. ,vol. 11, pp. 859- 871 ,(2006) , 10.1016/J.DEVCEL.2006.10.007